Latest filing published 03 Jan 2023 for Pharmiva AB (publ), €685.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anna Linton: trading record in brief
This profile gathers the share dealings of Anna Linton in Pharmiva AB (publ). In total, 4 filings cover trades dated from 28 September 2022 to 3 January 2023.
Every open-market trade on record is a purchase: 3 purchases worth €6,179, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2023 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €2,664. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 3 January 2023, reports an open-market purchase of €685 in Pharmiva AB (publ). Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Anna Linton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,646 shares@ SEK 1.64987.7% of flowAktieISIN SE0015530670FI:csv-23862713d09f304da42cCanonical exit: 2 Apr 2023 (T+90)
- 17,500 shares@ SEK 1.7029.8% of flowAktieISIN SE0015530670FI:csv-69d6ee41f065afca821cCanonical exit: 3 Apr 2023 (T+90)
- 18,940 shares@ SEK 1.6531.7% of flowAktieISIN SE0015530670FI:csv-cba27c3069e100b8c2bfCanonical exit: 20 Mar 2023 (T+90)
- 16,666 shares@ SEK 1.8030.8% of flowBTA (betald tecknad aktie)ISIN SE0018536922FI:csv-1fff1e526d56412dd064
4 of 4 declarations